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NO MORAL PANIC: PUBLIC HEALTH RESPONSES TO
ILLICIT FENTANYLS
Daniel Ciccarone, M.D., M.P.H.*

ABSTRACT/SUMMARY
Overdose deaths due to illicit fentanyl represent a historic crisis–one full of challenges. But this era is also one of historic opportunity to rebalance our drug policies in favor of demand reduction
(including treatment) and away from failed prohibitionist policies, reorienting to a healthier society resilient to problematic drug use.
I. A DRUG CRISIS

OF

HISTORIC PROPORTION

For the first time in 100 years, life expectancy at birth has gone
down in the United States three consecutive years from 2014 to 2017.1
In 1919, mortality rates increased because of the ravages of World
War I and the great influenza pandemic.2 Because these events disproportionately affected young people, life expectancy went down correspondingly. While the effects of the current COVID-19 pandemic are
unfolding—the full brunt of its effects on mortality and morbidity will
be unveiled over several years—we are plagued by another scourge:
drug poisoning that is disproportionately affecting young people and
decreasing total life expectancy.3 According to the latest formal data
from the U.S. Centers for Disease Control and Prevention (CDC),
there were 67,367 drug overdose deaths in the United States in 2018, a
tripling in rate from 6.1/100,000 US population in 1999 to 20.7/100,000
in 2018 (239% increase).4 Since the beginning of the opioid epidemic,
over 750,000 Americans have died from drug poisoning.5 Annual
deaths due to drug overdoses now exceed deaths due to car accidents,
* Professor, Department of Family and Community Medicine, University of California San
Francisco.
1. Sherry L. Murphy et al., Mortality in the United States, 2017, NCHS DATA BRIEF. NO. 328,
at 1 (Nov. 2018); Steven H. Woolf & Heidi Schoomaker, Life Expectancy and Mortality Rates in
the United States, 1959-2017, 322 JAMA 1996, 1998 (2019).
2. NCHS, NAT’L VITAL STATS. SYS., Drug Overdose Deaths in the United States, 1999–2018,
https://www.cdc.gov/nchs/data/databriefs/db356_tables-508.pdf#3.
3. Woolf & Schoomaker, supra note 1, at 1999.
4. Holly Hedegaard et al., Drug Overdose Deaths in the United States, 1999–2018, NCHS
DATA BRIEF NO. 356, at 1 (2020).
5. Id.
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gun violence, and even HIV at the height of the 1990s’ HIV
epidemic.6
A. The triple wave epidemic
The triple wave epidemic of overdose deaths stems from three classes of opioids: prescription opioid pills (“semi-synthetic opioids” in
Figure 1), heroin, and synthetic opioids other than methadone.7 Figure
1 shows three waves of opioid mortality, each wave cresting on top of
the one before it. In the first wave, overdoses related to opioid pills
started rising in the year 2000 and have steadily grown through 2016.8
The second wave saw overdose deaths due to heroin, which started
increasing clearly in 2007, surpassing the number of deaths due to
opioid pills in 2015.9 The third wave of mortality has arisen from
fentanyl, fentanyl analogues and other illicit synthetic opioids in the
drug supply, climbing slowly at first, but dramatically after 2013.10
Data from 2017 show synthetic opioid deaths continuing to rise, reaching a peak of over 28,000, while opioid pill and heroin overdose deaths
leveled off, albeit at very high levels of approximately 15,000 deaths in
each category.11 It is important to note that the latest provisional data
from the CDC shows the third wave—deaths due to fentanyls—continuing to rise with 48,729 deaths attributed to synthetic opioids in the
12-month period through July of 2020; an 48% increase from the 12month period August 2018 through July 2019.12

6. Josh Katz, Drug Deaths in America Are Rising Faster Than Ever, N.Y. TIMES (June 5,
2017), https://www.nytimes.com/interactive/2017/06/05/upshot/opioid-epidemic-drug-overdosedeaths-are-rising-faster-than-ever.html.
7. Daniel Ciccarone, The triple wave epidemic: Supply and demand drivers of the US opioid
overdose crisis, 71 INT’L J. DRUG POL’Y 183, 183–85 (2019).
8. NATIONAL CENTER FOR HEALTH STATISTICS, supra note 2.
9. Id.
10. Id.
11. Holly Hedegaard et al., Drug Overdose Deaths in the United States, 1999–2017, NCHS
DATA BRIEF NO. 329, at 4 (2018).
12. Provisional Drug Overdose Death Counts, CDC, NAT’L CTR. HEALTH STATS., https://
www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm (last updated Feb. 17, 2021) (last visited
Feb 24, 2021).
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B. Understanding fentanyls
Opioids are placed in three classes, based on their relationship to
opium: natural, semi-synthetic and synthetic.13 Natural opioids, often
called “opiates,” are derived from opium, a gum extract of the poppy
ovary; examples include morphine and codeine.14 Semi-synthetics are
derived from opium derivatives, such as morphine or thebaine (examples include well-known pharmaceutical opioids, such as
hydromorphone and oxycodone, as well as illicit heroin, i.e., diacetyl
morphine).15 Synthetic opioids have no relationship to opium-based
products and are produced in pharmaceutical facilities.16 Examples include fentanyl and methadone. Another way to classify opioids is by
their mechanism of action at the mu-receptor of the nervous system:
agonist, partial agonist, and antagonist.17 Many pain medications as
13. Kimberly D.L. Parks et al., The Pharmacology of Opioids, in THE ASAM PRINCIPLES
ADDICTION MEDICINE 135 (Abigail J. Herron & Timothy K. Brennan eds., 3d ed. 2020).
14. Id. at 135.
15. Id. at 136.
16. Id.
17. Id. at 138–42.
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well as most opioids with abuse potential are full mu-agonists.18 By
triggering the mu-receptor, they induce pain relief, as well as euphoria.19 Partial agonists are just that: weaker stimulators of the mu-receptor. A good example of a partial agonist is the medication
buprenorphine, considered an excellent choice in treating opioid use
disorder.20 Antagonists are essentially blockers of the mu-receptor,
and thus trigger no effect, except perhaps dislocating an agonist from
mu binding and reversing its effect; the overdose reversal agent naloxone is a good example of this action.21
Fentanyl and its chemical cousins, the fentanyl analogues, are synthetic opioids.22 Mother chemical fentanyl is a powerful agonist with
potency by volume a hundred times that of morphine and forty times
that of heroin.23 As a medication, fentanyl is successfully used in surgery, obstetrics, and end-of-life care24; it has both short-acting and
long-acting forms25 which, when used correctly, are tremendously useful. The street drug fentanyl that is fueling the current overdose crisis
is an illicitly manufactured product. According to the Drug Enforcement Administration (DEA), illicit fentanyl is mostly coming from
China or Mexico.26 There is Estonian and Russian production as well,
but those products do not come to the U.S.27 There have been waves
of fentanyls transported into the U.S. for three decades, the last one in
the Chicago region occurred in 2006; however, the most recent wave,
beginning in 2014, is the longest lasting and nationwide.28
My research team and I have the privilege of doing some research
in street-based settings, talking to persons who use drugs and observing heroin, fentanyl, and other drug use. This research helps gain a
rich cultural understanding of drug use, along with gaining the perspective of those most affected by the vicissitudes in supply and the
18.
19.
20.
21.
22.

Id. at 139–40.
Parks et al., supra note 13, at 136–39.
Id. at 141–42.
Id. at 144.
Joji Suzuki & Saria El-Haddad, A review: Fentanyl and non-pharmaceutical fentanyls, 171
DRUG & ALCOHOL DEPENDENCE 107, 107 (2017).
23. Daniel Ciccarone, Fentanyl in the US heroin supply: A rapidly changing risk environment,
46 INT’L J. DRUG POL’Y 107, 108 (2017).
24. Suzuki & El-Haddad, supra note 22, at 108.
25. Id.
26. U.S. DEP’T JUST., DRUG ENFORCEMENT ADMIN., 2016 NATIONAL DRUG THREAT ASSESSMENT SUMMARY vii (2016).
27. Sarah G. Mars et al., Illicit fentanyls in the opioid street market: desired or imposed?, 114
ADDICTION J. 774, 775 (2019).
28. Daniel Rosenblum et al., The Rapidly Changing US Illicit Drug Market and the Potential
for an Improved Early Warning System: Evidence from Ohio Drug Crime Labs, 208 DRUG &
ALCOHOL DEPENDENCE 1, 1–2 (2020).
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structural risks that are imposed on them. From a public health perspective, we are interested in understanding both imposed risk as well
as behavioral risk taking. These understandings better inform interventions to reduce the negative health outcomes. We have written extensively on fentanyl supply, risk, and perception.29 Among our
findings: fentanyls are a supply side phenomenon that were not driven
by demand from heroin users;30 most street-based fentanyls are not
sold as is,31 they are sold as fentanyl-adulterated or -substituted heroin
(FASH)32; fentanyl adulteration is occurring unbeknownst to users
and low-level dealers33; FASH is the norm in the areas of the country
with the highest overdose rates (i.e., the Midwest and New England
regions);34 the fentanyl component of FASH is unpredictable and
under constant change;35 and as fentanyl supply changes, overdose
risk changes.36 It is important to note that the cryptic nature of FASH
and the resultant vicissitudes in heroin and fentanyl potency are likely
driving overdose (more so than sheer potency alone). Fentanyls may
be here to stay; the continued presence of this deadly chemical class
over the last five years is evidence of its durable supply.37
II.

PARADOXES

OF

PROHIBITION

A. The failure of drug prohibition
Drug policy is roughly divided into two poles: demand reduction
and supply reduction. As noted, FASH is a supply-side imposition into
the US drug market.38 Since it is supply-sided, then why not simply
“turn off the tap”? Attempting to decrease the problem by curtailing
29. Sarah G. Mars et al., The Textures of Heroin: User Perspectives on “Black Tar” and Powder Heroin in Two U.S. Cities, 48 J. PSYCHOACTIVE DRUGS 270, 276–77 (2016); Daniel Ciccarone
et al., Heroin uncertainties: Exploring users’ perceptions of fentanyl-adulterated and -substituted
‘heroin’, 46 INT’L J. DRUG POL’Y 146, 147, 149, 152 (2017); Ciccarone, supra note 23, at 107;
Sarah G. Mars et al., Sold as Heroin: Perceptions and Use of an Evolving Drug in Baltimore,
MD, 50 J. PSYCHOACTIVE DRUGS 167, 168 (2018); Sarah G. Mars et al., Toots, tastes and tester
shots: user accounts of drug sampling methods for gauging heroin potency, 15 HARM REDUCTION
J. 1 (2018); Mars et al., supra note 27, at 774; Ciccarone, supra note 7, at 183; Rosenblum et al.,
supra note 28.
30. Mars et al., supra note 27, at 774–779.
31. Mars et al., Sold as Heroin, supra note 29, at 174.
32. Ciccarone et al., Heroin uncertainties, supra note 29, at 147.
33. Id. at 149.
34. Ciccarone, supra note 7, at 186
35. Mars et al., supra note 27, at 775–76.
36. Rosenblum et al., supra note 28, at 3–7.
37. U.S. DRUG ENFORCEMENT AGENCY, DEA INTELLIGENCE REPORT: FENTANYL FLOW TO
THE UNITED STATES 2–4 (2020).
38. Mars et al., supra note 27, at 779.
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supply does not work as well as desired, and in fact, having an excessive supply focus can have paradoxical results.
Supply control, including prohibition of drugs and the corollary penalization of drug use, has been the leading force in U.S. drug policy
for over a hundred years.39 The founding father of such prohibitionist
efforts, which began in the 1920s, was Henry Anslinger. President
Richard Nixon famously coined the term “war on drugs” to highlight
his administration’s efforts to curb the drug problem in the early
1970s. There is an extensive critical literature on the societal outcomes
of this so-called war on drugs. I want to focus on one paper that is
highly relevant to the current crisis.
FIGURE 2. MORTALITY

RATES FROM UNINTENTIONAL DRUG
OVERDOSES.

(A and B) Mortality rates for (A) individual drugs and (B) all
drugs. Detailed data for individual drugs are only available from 1999
to 2016, although additional data for all drugs are available since 1979
(this area is grayed out). The exponential equation and fit are shown
for all drugs. (Synth Opioids OTM: synthetic opioids other than methadone. This category includes fentanyl and its analogs.) From Jalal H,
Buchanich J, Roberts MS, Balmert LC, Zhang K, Burke DS. Changing dynamics of the drug overdose epidemic in the United States from
1979 through 2016, Science 21 Sep 2018:Vol. 361, Issue 6408,
39. DAVID T. COURTWRIGHT, DARK PARADISE: A HISTORY
AMERICA 1, 2 (2001).

OF

OPIATE ADDICTION
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eaau1184. DOI: 10.1126/science.aau1184. Reprinted with permission
from AAAS.
Science, a journal published by the American Association for the
Advancement of Science (AAAS), is the “premier global science
weekly” reporting on advances in scientific understandings in the
world.40 Hawre Jalal and colleagues reported the results of their analysis of thirty-eight years (1978–2016) of U.S. drug mortality data.41
They found an exponential growth in the drug-related death rate over
this time period (Figure 2). This exponential increase in drug-related
death rate was not defined by any specific class of drugs. Each era has
its problematic drug defined by supply or by cultural desire, but there
may be underlying drivers of problematic drug use leading to death
that are independent of the class of drug that continue to get worse
over time. Rising mortality due to opioids, including fentanyls, is only
the latest manifestation of this multi-decade phenomenon. There is no
doubt, however, that the triple wave has made the situation much
worse.
The reasons for this “worst case” public health scenario involves
two failures: first, that of drug prohibition to curb the problem, and
second, the failure to address the underlying, root causes of problematic drug use.
There is a metaphor used in drug policy when discussing the paradoxical effects of many supply interventions: that of the “balloon,”
considering that attempts to restrict supply are like squeezing a balloon and, as we all know, that leads to the balloon popping out in an
unexpected place. There are a number of solid academic analyses
which discuss the challenges of our long-standing drug prohibitionist
policies.42 One example highlights an unforeseen consequence of a
large-scale supply intervention.43 In the 1990s and 2000s, the U.S. supported intense efforts to reduce cocaine production in Colombia and
its export to the United States.44 These efforts included crop spraying
and supply route interdiction, as well as arrest, extradition, and sup40. AM. ASS’N ADVANCEMENT SCI., Scientific Journals, https://www.aaas.org/journals (last visited Mar. 10, 2021).
41. Harwe Jalal et al., Changing dynamics of the drug overdose epidemic in the United States
from 1979 through 2016, 361 SCIENCE 1218, 1218 (2018).
42. ROBERT J. MACCOUN & PETER REUTER, DRUG WAR HERESIES: LEARNING FROM OTHER
VICES, TIMES, & PLACES 21–22 (2001); PETER ANDREAS & ETHAN NADELMANN, POLICING THE
GLOBE: CRIMINALIZATION AND CRIME CONTROL IN INTERNATIONAL RELATIONS 21 (2006).
43. Daniel Ciccarone, Heroin in brown, black and white: Structural factors and medical consequences in the US heroin market, 20 INT’L J. DRUG POL’Y 277, 277–82 (2009).
44. Id. at 279.
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ported killing of drug cartel leaders.45 The goal was to negatively affect the historically high cocaine production at the time—at the height
of which approximately 1,000 metric tons were estimated to be produced each year.46 One unexpected result of this downward pressure
on cocaine was the introduction of poppy and heroin production for
the first time in Colombian history.47 Prior research noted that “[t]he
diversification of Colombian drug production and export to include
heroin in addition to cocaine, with the resultant increase in heroin
availability in the US, despite reduced supply from traditional sources,
highlights a paradoxical effect of interdiction.”48 The influx of new
Colombian-sourced heroin into the U.S. led to a nationwide decrease
in heroin price to historically low levels.49 The DEA’s metric for success in controlling a drug’s supply is increased price.50 Despite multidecade efforts to control heroin into this country, whether from Afghanistan, Colombia, or Mexico, heroin prices have been pushed to
generationally low levels.51
One under-recognized driver of drug mortality is demand and its
under-treated root causes.52 The demand-side argument examines the
structural factors that might be driving the triple wave overdose epidemic.53 The “diseases of despair” analyses highlight the extraordinary rise in death rates among the middle-aged White population
without a college degree in three related categories: drug poisoning,
alcohol-related disease, and suicide.54 The most compelling structural
determinants for opioid-related use and mortality include an aging
population with rises in reported pain and disability, economic distress, declining social cohesion and rising psychological malaise that
may have led an at-risk population to seek opioids in the first place.55
In this line of reasoning, increased prescription opioid supply is a
“vector” of the opioid overdose epidemic with more proximal root
45. Id.
46. UNITED NATIONS OFFICE FOR DRUG CONTROL AND CRIME PREVENTION, GLOBAL ILLICIT DRUG TRENDS 57 (2002).
47. Ciccarone, supra note 43 at 279.
48. Id. at 279.
49. Daniel Ciccarone et al., Impact of South American heroin on the US heroin market
1993–2004, 20 INT’L J. DRUG POL’Y 392, 399 (2009).
50. Id. at 392.
51. Id. at 399–400.
52. Nabarun Dasgupta et al., Opioid Crisis: No Easy Fix to Its Social and Economic Determinants, 108 AM. J. PUB. HEALTH 182, 183 (2018).
53. Id. at 183.
54. Elizabeth M. Stein et al., The Epidemic of Despair Among White Americans: Trends in the
Leading Causes of Premature Death, 1999–2015, 107 AM. J. PUB. HEALTH 1541, 1545 (2017).
55. Dasgupta et al., supra note 52, at 182–86.
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causes that have worsened structural forces accompanied by generational hopelessness and despair.56
B. Putting the genie “back in the bottle”
Using its authority under the Controlled Substances Act57 and in
response to the synthetic opioid overdose crisis, the DEA issued a
temporary scheduling order in February 2018 placing all current and
future fentanyl analogues, not already scheduled, in the Schedule 1
(most restricted) classification of drugs.58 This emergency power was
extended by the Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act until May 2021.59 This
amounts to a class-wide ban on manufacturing and supply of all members of this chemical family.
More than 1,400 fentanyl analogues have been synthesized as research chemicals and two hundred of these analogues have been studied pharmacologically.60 The DEA’s National Forensic Laboratory
Information Service is actively tracking over sixteen analogues which
have entered the illicit drug market.61 The public health concerns
center on the illicit fentanyl agonists which have abuse potential and
overdose risk due to their potency.62 It is important to keep in mind
that chemical structure alone does not tell us if there are potential
antagonists (like naloxone) and partial agonists (like buprenorphine)
in the family of fentanyls that may be useful in treatment.63 This is
important because given the potency of illicit fentanyl, we need to explore new antagonists to reverse overdose and new treatments to address greater dependency. We need better, perhaps stronger or longer
lasting, antagonists and partial agonists—and they may come from the
fentanyl class. The class-wide ban will potentially inhibit: (1) clinical
trials of novel beneficial fentanyls and (2) clinical understandings of
56. Id. at 182–83.
57. 21 U.S.C. §§ 801–904.
58. Schedules of Controlled Substances: Temporary Placement of Fentanyl-Related Substances in Schedule I, 83 Fed. Reg. 25 (proposed Feb. 6, 2018) (to be codified at 21 C.F.R. pt.
1308).
59. Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act, S. 3201, 116th Cong. (2020).
60. Nektaria Misailidi et al., Fentanyls continue to replace heroin in the drug arena: the cases of
ocfentanil and carfentanil, 36 FORENSIC TOXICOLOGY 12, 12 (2018).
61. U.S. DRUG ENFORCEMENT ADMIN., DIVERSION CONTROL DIV., NFLIS BRIEF: FENTANYL
AND FENTANYL-RELATED SUBSTANCES REPORTED IN NFLIS, 2015–2016 12 (2017).
62. Ciccarone, supra note 23, at 108.
63. Fentanyl Analogues: Perspectives on Classwide Scheduling, Hearing Before the House
Comm. on the Judiciary and Subcomm. on Crime, Terrorism, and Homeland Security, 116th
Cong. 4 (2020), available at https://www.congress.gov/116/meeting/house/110392/witnesses/
HHRG-116-JU08-Wstate-ComerS-20200128.pdf.
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how fentanyls adversely affect health, such as why overdose events are
so severe.
It is important to note that, as of the latest data, the currently active
class-wide ban has not yet shown to be effective. For example, drug
seizure data from the Ohio Bureau of Criminal Investigation’s (BCI)
crime lab from 2009 to 2018 (204,951 samples across 87 counties, providing 8,352 county-month observations) was used examine trends and
the relationship between drug seizures and overdose at the county
level.64 Ohio has been exceptionally hard-hit by the opioid crisis, especially the third wave: fentanyls.65 The drug seizure data analysis
shows the number of fentanyl analogues by year: the only fentanyl
analogue detected in 2015 was acetyl fentanyl; eight new analogues
appeared in 2016, six more appeared in 2017, and seven new analogues appeared in 2018.66 Other non-fentanyl synthetic opioids are
emerging: U-47700 in 2016, and U-48800, U-49900, and U-51754 in
2017. No decline in novel opioids over time was seen and the spillover to non-fentanyl synthetics is concerning.67 However, it is important to note that the DEA class-wide scheduling only took effect in
February 2018, so longitudinal study on the effects of this policy is
needed.68
In a commentary published in the International Journal of Drug
Policy in 2019, I argued that synthetic opioids may represent the “end
of interdiction.”69 The challenge is in detecting illicit flows since, due
to the very high potency of fentanyl, the volume relative to “traditional” drugs (like heroin) of smuggled shipments is low.70 One paradox of supply control was demonstrated in the alcohol prohibition of
the 1920s, which was termed the “Iron Law of Prohibition.” This
“law” predicts that drug weight and volumes go down, while potencies
go up, due to supply control.71 During Prohibition, the illicit alcohol
trade shifted from beer to high alcohol content liquors to avoid detection.72 We see evidence of this effect in the current triple wave opioid
crisis as supply pressures on opioid pills, especially those illicitly mar64. Rosenblum et al., supra note 28, at 1–11.
65. Id. at 2.
66. Id. at 4.
67. See generally id.
68. Schedules of Controlled Substances: Temporary Placement of Fentanyl-Related Substances in Schedule I, 83 Fed. Reg. 25 (proposed Feb. 6, 2018) (to be codified at 21 C.F.R. pt.
1308).
69. Ciccarone, supra note 7, at 186.
70. Id.
71. Leo Beletsky & Corey S. Davis, Today’s fentanyl crisis: Prohibition’s Iron Law, revisited,
46 INT’L J. DRUG POL’Y 156, 157 (2017).
72. Id.
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keted, shifted the street market to higher potency heroin and then to
even higher potency fentanyl.73 The new “Iron Law” suggests that
highly potent-by-volume drugs like fentanyl are expected due to the
honing effects of interdiction.
Why is it so hard to get the fentanyl supply genie back in the bottle?
In a recent publication, The Future of Fentanyl, Bryce Pardo and colleagues discuss the drivers of the synthetic opioid market in the U.S.:
increased profitability, lack of regulatory capacity in the main source
country, China, as well as technological advancements in purchasing
(i.e., cryptocurrencies) and routing.74 The change in source-country of
our imported illicit opioids is important: from known criminal trafficking organizations within Afghanistan, Colombia, and Mexico, to new
source-countries like China. In addition, moving from agriculturalbased drugs, such as poppy-derived heroin, to lab-based drugs, like
fentanyls, makes the sourcing and routing more challenging to detect.
In addition, the technology to produce fentanyls is mobile; if China
were able to crack down on domestic illicit production, the supply balloon could squeeze production to another new source-country.
Making the class-ban on fentanyl permanent will also likely increase
trends in federal prosecution of fentanyl trafficking. Sentencing commission data show dramatic increases in fentanyl trafficking offenders,
disproportionately among persons of color, with 41% having no prior
criminal record and 50% at the bottom of the distribution chain.75
Over half of those charged/convicted did not know they were selling
fentanyl.76
C. No moral panic
Sociologists and criminologists talk about “moral panics” when society collectively acts out of instinct or fear.77 We saw this pervasive
fear-based reaction when HIV infection became an epidemic in the
1990s and those living with AIDS were shunned and treated prejudi73. Ciccarone, supra note 7, at 189.
74. BRYCE PARDO ET AL., THE FUTURE OF FENTANYL AND OTHER SYNTHETIC OPIOIDS
XV–XXVVIII (2019).
75. Public Data Presentation for Synthetic Cathinones, Synthetic Cannabinoids, Fentanyl and
Fentanyl Analogues Amendments, U.S. SENTENCING COMMISSION (Jan. 2018) https://
www.ussc.gov/sites/default/files/pdf/research-and-publications/data-briefings/2018_syntheticdrugs.pdf; Quick Facts: Fentanyl Trafficking Offenses, U.S. SENTENCING COMMISSION, https://
www.ussc.gov/sites/default/files/pdf/research-and-publications/quick-facts/Fentanyl_FY18.pdf
(last viewed Mar. 12, 2021).
76. Id.
77. Chas Critcher, Moral Panics, CRIMINOLOGY & CRIM. JUST., OXFORD RES. ENCYCLOPEDIAS (Mar. 29, 2017), available at https://oxfordre.com/criminology/view/10.1093/acrefore/
9780190264079.001.0001/acrefore-9780190264079-e-155.
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cially. In that era, stigma and shame were seen as political tools to
restrain sexuality and “degay” the at-risk population.78 Commonly believed, but irrational, fears of HIV infection through casual contact
contributed to this.79
The notion of moral panic often fits in describing our collective response to problematic drug waves. Caroline Acker summarizes this
recurrent theme in her book, Creating the American Junkie: “In recent
decades, one drug has succeeded another in the headlines, each accompanied by admonitions that it is uniquely addictive or likely to
produce bizarre behavior.”80 The response to each drug wave, more
often than not, has emphasized punitive over therapeutic measures.81
Crack (cocaine bicarbonate) use was particularly demonized as a social “plague.” Reinarman and Levine, in their edited volume, Crack in
America, emphasize the misdirection inherent in these panics: “The
crack scare, like previous drug scares and antidrug campaigns, promoted misunderstandings of drug use and abuse, blinded people to
the social sources of many social problems (including drug problems),
and constrained the social policies that might reduce those
problems.”82 Moral panics, by putting excessive focus on behavior and
behavior change, tend to “blame the victim.” Mannion and Small, in a
recent essay, sum the issue well: “Blaming individuals and groups for
the health needs they manifest leads to a focus on disciplinary power
and, in so doing, ignores underlying biological and structural causes
and puts undue and counter-productive pressure on the vulnerable.”83
The moral panic over fentanyl leads to irrational claims, such as the
fear that fentanyl cannot be touched or that fentanyl is being deliberately put into all substances, and subsequent responses, including a
rise in tougher penalties for fentanyl use/possession/manufacture.84
Fear, moral panic, and penalization of drug use all lead to stigma and
marginalization of the affected population. The consequences of wide78. GABRIEL ROTELLO, SEXUAL ECOLOGY: AIDS AND THE DESTINY OF GAY MEN 113–17
(1997).
79. SIMON WATNEY, POLICING DESIRE: PORNOGRAPHY, AIDS, AND THE MEDIA 38–57 (3d
ed. 1997).
80. CAROLINE JEAN ACKER, CREATING THE AMERICAN JUNKIE: ADDICTION RESEARCH IN
THE CLASSIC ERA OF NARCOTIC CONTROL 1–12 (2002).
81. Id.
82. CRAIG REINARMAN & HARRY G. LEVINE, Crack in Context: America’s Latest Demon
Drug, in CRACK IN AMERICA: DEMON DRUGS AND SOCIAL JUSTICE 46 (Craig Reinarman &
Harry G. Levine eds., 1st ed. 1997).
83. Russell Mannion & Neil Small, On Folk Devils, Moral Panics and New Wave Public
Health, 8 INT’L J. HEALTH POL’Y & MGMT 678, 682 (2019).
84. MICHAEL COLLINS & SHEILA P. VAKHARIA, CRIMINAL JUSTICE REFORM IN THE
FENTANYL ERA: ONE STEP FORWARD, TWO STEPS BACK 3–4 (2020).
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spread moral panic run counter to the goals of public health, which
seeks to encourage individuals to come forward for prevention and
treatment services. Instead, moral panic induces individuals to run and
hide.
III. THE WAY FORWARD
I have lost too many colleagues, patients, and research participants
to overdose. I understand the desire to act and the need to do something to reduce the carnage. But I also know the danger of moral
panic and the stigmatizing effects of excessively punitive approaches
and exuberant supply reduction approaches. By increasing stigma—a
very powerful force in human nature—they are simply counterproductive to the goals of public health.
Fentanyls are likely here to stay. They are the new norm. Instead of
fear, let us respond with a public health orientation of science, reason,
and compassion.
In meeting with criminal justice leaders at various national meetings
held by the National Institute of Justice, DEA, High Intensity Drug
Trafficking Areas (HIDTAs) among others, they have stated that
“[w]e are not going to arrest our way out of this.” They, and leaders at
the Office of National Drug Control Policy (ONDCP), have called for
public health/public safety partnerships.”85 These shifts in political
tone from leadership – and public perspective – favor treatment over
incarceration.
Chauncey Parker, Executive Assistant District Attorney in the
Manhattan District Attorney’s Office and Director of the New York/
New Jersey HIDTA program often speaks of his “North Star” in tackling the fentanyl problem: to reduce deaths. So what strategies are
most likely to reduce deaths?
- Offer treatment over punishment. Pre-arrest diversion86 and
other strategies to move individuals from prosecution to medical
help for their substance use disorder have a growing evidence
base of effectiveness.87
85. COMMUNITY ORIENTED POLICING SERVICES & POLICE EXECUTIVE RESEARCH FORUM,
BUILDING SUCCESSFUL PARTNERSHIPS BETWEEN LAW ENFORCEMENT AND PUBLIC HEALTH
AGENCIES TO ADDRESS OPIOID USE 3–7 (2016).
86. Jac Charlier, Pre-Arrest Diversion (PAD): Emerging Issues and Example Policy Responses, TASC CTR. HEALTH & JUST., https://www.centerforhealthandjustice.org/TascBlog/
images/documents/Publications/Pre-ArrestDiversion-IssuesandPolicy_SlideShow.pdf (last visited
Mar. 12, 2021).
87. Henry J. Steadman & Michelle Naples, Assessing the effectiveness of jail diversion programs for persons with serious mental illness and co-occurring substance use disorders, 23 BEHAV.
SCI. & L. 163, 163 (2005).
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- Expand treatment for opioid use disorder. Medically assisted
treatment (MAT) includes three medications, i.e., methadone,
buprenorphine and extended-release naltrexone, shown to be
medically effective and cost-effective.88 A recent meta-analysis
showed impressive reductions in mortality attributable to receipt
of MAT.89 Buprenorphine is one of the more efficacious from a
public health standpoint as it can be prescribed by primary care
providers, thus greatly expanding treatment availability. However, regulatory burdens, like mandatory prescriber training and
DEA licensing inscribed in the DATA 2000 law authorizing its
use, has led to lower levels of prescriber uptake.90 The Mainstreaming Addiction Treatment Act of 2019, with House
(H.R.248291) and Senate (S.207492) versions, attempts to address
the barriers inherent in the original legislation.
- Increase federal funding. Federal legislative efforts to address
the opioid crisis, including the Comprehensive Addiction and
Recovery Act (CARA)93 and the Substance Use Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT)94 are quite helpful, yet
much more is needed. Overdose deaths from all opioids have
continued to rise: a 29% year-over-year increase through July
2020, according to CDC provisional data.95
- Greater support for prevention. Harm reduction ideas and prevention technologies, once controversial, are gaining both evidence and acceptance.96 The goal of harm reduction is to reduce
deaths and other harms from drug use.97 Because it is personcentric and non-judgmental, it can reduce stigma and lead to
greater engagement with individuals who use drugs – it can even
88. Nora D. Volkow et al., Medication-Assisted Therapies—Tackling the Opioid-Overdose Epidemic, 370 NEW ENG. J. MED. 2063, 2065 (2014). More recent terminology is “medications for
opioid use disorder” (MOUD).
89. Jun Ma et al., Effects of medication-assisted treatment on mortality among opioids users: a
systematic review and meta-analysis, 24 MOLECULAR PSYCHIATRY 1868, 1868 (2018).
90. Kevin Fiscella et al., Buprenorphine Deregulation and Mainstreaming Treatment for
Opioid Use Disorder: X the X Waiver, 76 JAMA PSYCHIATRY 229, 229 (2019).
91. Mainstreaming Addiction Treatment Act of 2019, H.R. 2482, 116th Cong. (2019).
92. Mainstreaming Addiction Treatment Act of 2019, S. 2074, 116th Cong. (2019).
93. Comprehensive Addiction and Recovery Act, S. 524, 114th Cong. (2016) (enacted).
94. SUPPORT for Patients and Communities Act, H.R. 6, 115th Cong. (2018) (enacted).
95. 12 Month-ending Provisional Number of Drug Overdose Deaths, CDC, NAT’L CTR.
HEALTH STATS., https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm#dashboard (last updated Feb. 7, 2021) (last visited Mar. 5, 2021).
96. Alison Ritter & Jacqui Cameron, A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs, 25 DRUG ALCOHOL REV. 611, 618–19 (2006).
97. Dan Ciccarone, Henceforth harm reduction?, 23 INT’L J. DRUG POL’Y 16, 16 (2012).
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serve as a bridge to treatment. Interventions, such as syringe service programs, are now supported by such leaders as former
HHS Assistant Secretary Brett Giroir at the Department of
Health and Human Services. Naloxone distribution, once quite
controversial, is also endorsed by former U.S. Surgeon General
Jerome Adams. Bolder ideas include supervised consumption
services98 and heroin-assisted treatment.99
- Surveillance of the drug supply, a possible element of a public
health/public safety partnership, can potentially act as an early
warning system alerting front-line responders and those who use
drugs to dangerous changes in supply.100 Another emerging approach includes drug checking. Heroin users who used fentanyl
immunoassay test strips to check for fentanyl had greater odds of
positive changes in behavior.101
IV.

CONCLUSION

At this moment we are still working on yesterday’s problem. The
fourth wave of the opioid crisis sees a shift in use patterns to include
methamphetamine and cocaine with dramatically rising curves in stimulant-related deaths.102 To end the multi-decade, multi-generational
exponential increase in drug mortality, we need bold, creative, and
perhaps novel responses. There is growing evidence that we need to
address the socioeconomic determinants of health if we are to “fill in
the cracks” of society that the waves of drug supply fall into.103
In collaboration with Josh Katz at the New York Times, thirty experts were asked to think “big, but realistically, about solutions. Imagine you had $100 billion to spend over five years — a little less than
current federal domestic H.I.V./A.I.D.S. spending — to address the
98. Chloé Potier et al., Supervised injection services: what has been demonstrated? A systematic
literature review, 145 DRUG & ALCOHOL DEPENDENCE 48, 48–68 (2014).
99. BEAU KILMER ET AL., CONSIDERING HEROIN-ASSISTED TREATMENT AND SUPERVISED
DRUG CONSUMPTION SITES IN THE UNITED STATES vi–xii (2018).
100. Ciccarone, supra note 7, at 187; Rosenblum et al., supra note 28, at 8.
101. Nicholas C. Peiper et al., Fentanyl test strips as an opioid overdose prevention strategy:
Findings from a syringe services program in the Southeastern United States, 63 INT’L J. DRUG
POL’Y 122, 122 (2019).
102. Berkshire District Attorney’s Office, “Fourth Wave of the Opioid Epidemic: Polysubstance Use” Hosted by Berkshire District Attorney’s Office and the Berkshire Opioid Addiction
Prevention Collaborative, MASS. (Aug. 21, 2020), https://www.mass.gov/news/fourth-wave-of-theopioid-epidemic-polysubstance-use-hosted-by-berkshire-district-attorneys (last viewed Mar. 5,
2021).
103. Dasgupta et al., supra note 52, at 186–87.
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opioid crisis. Where would you put that money?”104 The composite
answer was a revelation: a comprehensive and balanced plan including
harm reduction, treatment, demand reduction (including community
development), and supply reduction.105 This schematic has been
turned into policy platforms for a number of top political figures—its
implementation could signal the end of an unfortunate era.

104. Josh Katz, How a Police Chief, a Governor and a Sociologist Would Spend $100 Billion to
Solve the Opioid Crisis, N.Y. TIMES (Feb. 14, 2018), https://www.nytimes.com/interactive/2018/
02/14/upshot/opioid-crisis-solutions.html.
105. Id.

